Takeda Pharmaceutical Company Limited Stock
Stocks
4502
JP3463000004
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Japan Exchange
04:30:00 20/08/26 pm AEST
|
5-day change | 1st Jan Change | ||
| 5,825.00 JPY | +0.97% |
|
+4.79% | +20.48% |
| 12:32am | Pharma sector doubles down on AI amid hopes of slashing costs, timelines | RE |
| 19/08 | Asian Equities Traded in the US as American Depositary Receipts Track Lower in Tuesday Trading | MT |
| Market Cap | 9,212B 58.12B 49.85B 46.55B 42.71B 80.32B 5,555B 81.64B 549B 215B 2,786B 218B 213B | P/E 2027 * |
47.1x | P/E 2028 * | 30.1x |
|---|---|---|---|---|---|
| Enterprise Value | 13,114B 82.74B 70.97B 66.27B 60.8B 114B 7,908B 116B 782B 306B 3,966B 311B 304B | EV / Sales 2027 * |
2.8x | EV / Sales 2028 * | 2.71x |
| Free-Float |
99.28% | Yield 2027 * |
3.54% | Yield 2028 * | 3.61% |
Last Transcript: Takeda Pharmaceutical Company Limited
| 1 day | +0.97% | ||
| 1 week | +4.79% | ||
| Current month | +5.66% | ||
| 1 month | +4.86% | ||
| 3 months | +10.85% | ||
| 6 months | +0.60% | ||
| Current year | +20.48% |
| 1 week | 5,504 |  | 5,840 |
| 1 month | 5,225 | | 5,903 |
| Current year | 4,710 | | 6,033 |
| 1 year | 4,102 | | 6,033 |
| 3 years | 3,852 | | 6,033 |
| 5 years | 2,993 | | 6,033 |
| 10 years | 2,894.5 | | 6,693 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 01/01/2025 | |
Mikuno Furuta
DFI | Director of Finance/CFO | 48 | 01/04/2024 |
Gabriele Ricci
CTO | Chief Tech/Sci/R&D Officer | 47 | 01/02/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Andrew Plump
BRD | Director/Board Member | 60 | 01/06/2015 |
Steven Gillis
BRD | Director/Board Member | 73 | 01/01/2019 |
Mikuno Furuta
BRD | Director/Board Member | 48 | 01/06/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 11/8/26 | Sell | Pres., Global Supply & Quality | -20,363 | 0.0013% | ||
| 10/8/26 | Sell | Pres., Global Supply & Quality | -3,978 | 0.0002% | ||
| 10/8/26 | Sell | Chief Executive Officer | -89,090 | 0.0056% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.97% | +4.79% | +27.66% | +32.75% | 58.12B | |
| -1.51% | +4.30% | +78.76% | +129.26% | 1,141B | |
| -1.17% | +3.22% | +51.26% | +61.65% | 659B | |
| -1.08% | +5.42% | +26.42% | +76.09% | 470B | |
| +0.27% | +1.71% | +40.43% | +44.91% | 366B | |
| -1.27% | +1.65% | +22.88% | +39.76% | 302B | |
| -0.90% | +1.94% | -0.34% | +11.82% | 254B | |
| -2.23% | +3.87% | +46.40% | +66.47% | 239B | |
| -1.07% | -0.52% | -14.15% | -52.95% | 207B | |
| -2.21% | +4.33% | +21.38% | +89.78% | 183B | |
| Average | -1.05% | +4.06% | +30.07% | +49.95% | 387.91B | |
| Weighted average by Cap. | -1.22% | +4.30% | +44.18% | +71.83% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 4,684B 29.55B 25.35B 23.67B 21.72B 40.84B 2,824B 41.51B 279B 109B 1,417B 111B 109B | 4,758B 30.02B 25.75B 24.05B 22.06B 41.49B 2,870B 42.17B 284B 111B 1,439B 113B 110B |
| Net income | 191B 1.2B 1.03B 964M 884M 1.66B 115B 1.69B 11.37B 4.45B 57.67B 4.52B 4.42B | 313B 1.98B 1.69B 1.58B 1.45B 2.73B 189B 2.77B 18.67B 7.31B 94.68B 7.42B 7.25B |
| Net Debt | 3,902B 24.62B 21.12B 19.72B 18.09B 34.02B 2,353B 34.58B 233B 91.12B 1,180B 92.44B 90.43B | 3,701B 23.35B 20.03B 18.7B 17.16B 32.27B 2,232B 32.8B 221B 86.42B 1,119B 87.68B 85.77B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/08/26 | JPY 5,825.00 | +0.97% | 5,268,300 |
| 19/08/26 | JPY 5,769.00 | +1.18% | 6,779,900 |
| 18/08/26 | JPY 5,702.00 | +3.43% | 4,655,200 |
| 17/08/26 | JPY 5,513.00 | -1.75% | 2,529,900 |
| 14/08/26 | JPY 5,611.00 | +0.94% | 4,376,500 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4502 Stock
Select your edition
All financial news and data tailored to specific country editions
